More on NBIX
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Sponsored research and development | |
| Milestones and license fees | |
| Total revenues | 0 |
| Research and development | 20.94M |
| General and administrative | 17.49M |
| Cease-use expense | |
| Total operating expenses | 38.44M |
| Income (loss) from operations | -38.44M |
| Gain on sale/disposal of assets | |
| Deferred gain on real estate | 853K |
| Investment income and (expense), net | |
| Other income, net | |
| Total other income | 1.55M |
| Net income (loss) | -36.89M |
| Basic | |
| Diluted | |
| Basic | |
| Diluted | |
Entities mentioned with NBIX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
